In breast cancer, TFAP2C induces expression of ERα as well as other ERα-associated genes while represses expression of basal-associated gene [8–10], playing crucial role in maintaining the luminal phenotype of breast cancer. This evidence concerns the gene ESR1 and breast carcinoma.